Free Trial

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $6.02 Million Holdings in Baker Hughes (NASDAQ:BKR)

Baker Hughes logo with Oils/Energy background

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lessened its holdings in Baker Hughes (NASDAQ:BKR - Free Report) by 13.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 166,504 shares of the company's stock after selling 25,190 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in Baker Hughes were worth $6,017,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of BKR. Eagle Asset Management Inc. raised its position in shares of Baker Hughes by 18.6% in the third quarter. Eagle Asset Management Inc. now owns 5,486,207 shares of the company's stock valued at $198,326,000 after purchasing an additional 860,219 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Baker Hughes by 436.0% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,004,647 shares of the company's stock worth $36,318,000 after purchasing an additional 817,227 shares during the period. Robeco Institutional Asset Management B.V. boosted its position in shares of Baker Hughes by 63.9% in the third quarter. Robeco Institutional Asset Management B.V. now owns 2,001,870 shares of the company's stock valued at $72,368,000 after acquiring an additional 780,417 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Baker Hughes during the third quarter worth $27,914,000. Finally, Legal & General Group Plc boosted its holdings in Baker Hughes by 8.6% in the 2nd quarter. Legal & General Group Plc now owns 8,723,388 shares of the company's stock valued at $306,801,000 after purchasing an additional 692,859 shares during the period. 92.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently weighed in on BKR shares. BMO Capital Markets lifted their price objective on Baker Hughes from $43.00 to $45.00 and gave the stock an "outperform" rating in a report on Thursday, October 10th. UBS Group reduced their price objective on shares of Baker Hughes from $42.00 to $40.00 and set a "neutral" rating for the company in a report on Wednesday, September 18th. Argus upgraded shares of Baker Hughes from a "hold" rating to a "buy" rating in a research report on Friday, October 25th. Benchmark reissued a "buy" rating and issued a $42.00 price target on shares of Baker Hughes in a research report on Thursday, October 24th. Finally, Morgan Stanley raised their price target on shares of Baker Hughes from $42.00 to $45.00 and gave the stock an "overweight" rating in a research note on Thursday, October 3rd. Two research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $44.76.

View Our Latest Stock Report on BKR

Baker Hughes Trading Down 0.0 %

Shares of Baker Hughes stock traded down $0.02 during trading on Tuesday, reaching $43.67. 3,583,562 shares of the company were exchanged, compared to its average volume of 6,326,440. The business has a 50-day moving average price of $39.68 and a 200-day moving average price of $36.19. The firm has a market capitalization of $43.21 billion, a price-to-earnings ratio of 19.58, a P/E/G ratio of 0.74 and a beta of 1.40. The company has a quick ratio of 0.88, a current ratio of 1.30 and a debt-to-equity ratio of 0.37. Baker Hughes has a twelve month low of $28.32 and a twelve month high of $45.17.

Baker Hughes (NASDAQ:BKR - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.06. The business had revenue of $6.91 billion for the quarter, compared to analyst estimates of $7.21 billion. Baker Hughes had a net margin of 8.20% and a return on equity of 13.77%. Baker Hughes's quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.42 EPS. Sell-side analysts anticipate that Baker Hughes will post 2.29 EPS for the current fiscal year.

Baker Hughes Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 14th. Investors of record on Monday, November 4th were paid a dividend of $0.21 per share. The ex-dividend date was Monday, November 4th. This represents a $0.84 dividend on an annualized basis and a yield of 1.92%. Baker Hughes's payout ratio is 37.67%.

Baker Hughes Profile

(Free Report)

Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain worldwide. The company operates through Oilfield Services & Equipment (OFSE) and Industrial & Energy Technology (IET) segments. The OFSE segment designs and manufactures products and provides related services, including exploration, appraisal, development, production, rejuvenation, and decommissioning for onshore and offshore oilfield operations.

Featured Articles

Institutional Ownership by Quarter for Baker Hughes (NASDAQ:BKR)

Should you invest $1,000 in Baker Hughes right now?

Before you consider Baker Hughes, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baker Hughes wasn't on the list.

While Baker Hughes currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group (UNH) is a powerhouse in healthcare, offering an impressive 14.7% average annual dividend increase over the last three years.

Related Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines